Image1_Increased CD34 in pancreatic islet negatively predict islet β-cell decrease in type1 diabetes model.TIF

<p>Islet β-cell biomarkers can reflect changes in the number and function of islet β-cells in the prediabetes or early diabetes stage. CD34 is a commonly used stem cell biomarker; however, its expression and function in pancreatic islets remain unclear. In the present study, double immunofluorescenc... View More